Rare case of left adrenal cortical carcinoma with level 3 inferior vena cava thrombus via adrenal vein by Jain, K et al.
African Journal of Urology (2017) 23, 201–203
African  Journal  of  Urology
Official journal of the Pan African Urological Surgeon’s Association





Rare  case  of  left  adrenal  cortical  carcinoma  with
level  3  inferior  vena  cava  thrombus  via  adrenal
vein
K.  Jain ∗,  R.K.  Gopala  Krishna  ,  S.  Basu
Department  of  Urology,  Fortis  Hospital  Limited,  Kolkata,  India
Received 30 August 2016; received in revised form 23 October 2016; accepted 2 December 2016







Introduction:  Adrenocortical carcinoma (ACC) is a rare malignancy with an incidence of 0.7–2.0
cases/million habitants/year. It shows a bimodal pattern of age distribution with a higher incidence in
the first decade and then between 40 and 50 years. Women are most frequently affected (55–60%).
Observation:  A 21-year-old male, incidentally detected with left supra renal tumor invading the left renal
vein and the thrombus extending into the supra diaphragmatic IVC, underwent laparotomy with simultaneous
median sternotomy on total cardiac bypass for removal of IVC tumor thrombus and radical excision of the
tumour with left nephrectomy and spleenectomy. The histopathology report came to be adrenal cortical
carcinoma with no renal parenchymal invasion and the immuno-histochemistry showing it to be positive
for synaptophysin, inhibin and KI-67 (15%) while negative for chromogranin, pan cytokeratin and CD-10
receptors. Patient then received 3 weekly 6 cycles of adriamycin and cisplatin chemotherapy. Bone scan and
CECT abdomen and thorax done in the follow up after two years were normal. There are not many cases
of adrenal carcinoma reported in the literature, but it has been seen that it rarely shows venous thrombosis
in the IVC. In all the reported cases radical surgery is the preferred treatment option, even in the tumors
extending to the right atrium. The unique feature in our case is that the tumor has extended to the supra
diaphragmatic IVC via the left adrenal vein, without the renal parenchyma involvement.
Conclusion:  The intravascular extension of the adrenal carcinoma is rare but its presence alone is not a
contraindication to radical surgery, as it is the best hope for prolonged survival.
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Figure  2  CECT image coronal view of level 3 IVC thrombus.











igure  1  CECT image axial view of left adrenal tumor with renal
ein and IVC thrombus.
ith peak incidence in first and the fifth decade of life and is more
ommon in females (55–60%) [1]. Approximately 40–60% cases
resents with symptoms of steroid hormone excess, most commonly
eing cortisol, 30% cases presents with symptoms related to abdom-
nal mass effects and 15–20% cases are incidentally diagnosed [2].
t is an aggressive tumor with early metastasis and approximately
0% cases present with disseminated disease and metastasis in: lung
71%), lymph nodes (68%), liver (42%) and bone (26%) [3]. Venous
umor thrombosis to IVC or atrium is rare and is considered as a
umor extension instead of metastatic disease, but with a poor prog-
ostic outcome. Involvement of vena cava can occur through direct
xtension or more often by intraluminal extension from renal or
drenal vein. In such cases, radical surgery with removal of the
umor and the thrombus may give better treatment outcome [4].
ase  report
 21 year old male presented with right flank pain and low grade
ever was incidentally detected with left supra renal tumor with
all stones on ultrasonogram. There was no history of any urinary
omplaints and no significant family history. On examination, the
atient was stable with no palpable abdominal lump. On further eval-
ation by contrast enhanced CT, 11.3 ×  11.0 cm heterogeneously
nhancing mass lesion, with necrotic component within it, in rela-
ion to the upper pole of left kidney was detected with level 3 tumor
hrombus invading into the left renal vein and extending into the
VC excluding just 2.5 cm of the extra cardiac IVC (Figs. 1 and 2).
o bony lesions were seen. Two small lung nodules suspicious of
etastasis were also seen but confirmation by either biopsy or PET
can was not possible due to the small size. Urinary metanephrines,
anillyl-mandelic acid and other serum adrenal hormone profile lev-
ls were within normal limits. The routine blood investigations were
ithin normal limits. The patient was then taken up for laparotomy
ith simultaneous median sternotomy in collaboration with car-
io thoracic surgeon. Trans esophageal echocardiography showed
umor extension into the supradiaphragmatic IVC just peeping into
he right atrium. With total circulatory arrest, IVC was snugged
t its junction with right atrium and then opened longitudinally in
he abdomen for tumor thrombectomy. The total hypothermia time





arenchyma and the tumor thrombus extending from adrenal vein to the
enal vein.
ue to adhesions and infiltration, was done. The total operative time
as about 8 h and the estimated blood loss was one litre. Patient
as managed in the ICU for two days. He received two units of
lood transfusion for the blood loss. He developed minimal surgical
ite infection and chest infection which was managed by antibi-
tics; otherwise he recovered well and was discharged on the post
perative day seven. The histopathology report came to be adrenal
ortical carcinoma with no renal parenchymal or surrounding tis-
ue invasion and identical tumor tissue in the renal vein and IVC
hrombus (Fig. 3). Single hilar lymph node isolated was free of
umor. Immuno-histochemistry showed it to be positive for synap-


































Adrenal tumors with venous thrombosis: a single-institution experience.
Urol Int 2011;87(2):182–5.Left adrenal cortical carcinoma with level 3 IVC thrombus 
pan cytokeratin and CD-10 receptors. The tumor was classified as
European Network for the Study of Adrenal Tumours (ENSAT)
stage III due to the presence of venous tumor thrombus with poor
prognosis due to Ki-67 being >10%. Patient then received 3 weekly
6 cycles of adriamycin and cisplatin chemotherapy. CECT abdomen
and thorax was done in the follow up period of two years and was
found to be normal with the resolution of the lung nodules as well.
We followed the follow up protocol of CECT abdomen and chest
every 3 months for 2 years and thereafter 6 monthly for 5 years.
Discussion
Adrenal cortical carcinoma is a rare disease and the venous tumor
thrombus to IVC or atrium is even rarer. Nakanoma et al. reported a
similar case of left adrenal tumor with intracaval extension managed
by radical surgery involving resection of tumor, left kidney, spleen
and IVC tumor thrombus. They reported it as being the 8th case
report in the literature [5]. Osman et al. in their study of 206 patients,
who underwent adrenal surgery, concluded that venous thrombosis
with adrenal tumors is a rare pathological condition in which open
surgery is the standard of care. Also they reported that these patients
of primary adrenal malignancy with venous thrombosis have a poor
prognostic outcome [6].
In the literature, it is suggested that complete tumor resection is the
only curative approach to adrenal cortical carcinoma with adjuvant
therapies aiming to decrease the risk of recurrence only. Thus, an
aggressive surgical approach is the treatment of choice even in cases
with tumor thrombus reaching the right atrium. For patients who are
unfit for surgery or who refuse radical surgery, chemotherapy can be
tried. Mitotane is the most effective and frequently used chemother-
apeutic agent in metastatic adrenal carcinoma and in combination
with cisplatin, doxorubicin and etoposide, it has produced a clin-
ical response rate of about 50% even in advanced cases. But it is
also known for its toxicity involving the nervous system (ataxia,
amnesia, confusion) and gastro-intestinal system (nausea, diarrhea,
vomiting). Hence, in patients who do not tolerate or afford mitotane,
other chemotherapeutic agents such as cyclophophamide, doxoru-
bicin and cisplatin can be tried. The role of radiotherapy is not well
defined and is limited to bone metastases only in which it is the
treatment of choice.
Due to the aggressive nature of the tumor and quick development
of metastasis, early diagnosis gives the best chance of resection
and hence the greatest chances of survival. There are many newer
investigations to provide an early diagnosis. Urinary steroid profil-
ing (USP), which uses gas chromatography/mass spectrometry to
detect small amount of steroid precursors in apparently non func-
tional tumors, is under review in the SERENDIPITY-trial for its
cost effectiveness in the work-up of adrenal tumors. Measurement
of circulating tumor cells in the blood stream may be a valuable
early marker for detection of malignancy and for disease progres-
sion or treatment monitoring. The 11C-metomidate (MTO) “11C
MTO-PET” scan using tracer ‘mitomidate’ that specifically bind to
adrenocortical CYP11B enzymes can be useful to prove adrenocor-
tical origin.
Prognosis of adrenal carcinoma is poor and the five years survival
rate decreases further with higher ENSAT (European Network for
[
203
he Study of Adrenal Tumors) stage (Stage 1: 66–82%, Stage 2:
8–64%, Stage 3: 24–50%, Stage 4: 0–17%), incomplete micro-
copic resection (R1: 20% overall survival) or macroscopic resection
R2: 15% overall survival) of the tumor and the proliferation index
Ki67 >10% and mitotic count >20 mitosis/50 HPF) [7].
onclusion
CC is a rare and malignant tumor with unclear pathogenesis and
 poor prognosis. Vascular tumor thrombus to IVC and atrium is
urther rare and more common on the right side due to proximity to
he vessel. Surgery is the treatment of choice even in the presence
f extensive tumor thrombus—thus early diagnosis gives the best
hance of resection, and the greatest chances of survival. Mitotane
as been the backbone of medical therapy but newer targeted therapy
as to be developed to decrease reliance on this old and toxic drug.
onsent
ritten consent was taken from the patient to undergo surgical
rocedure and oral consent was given by the patient for this case
eport.
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